Statistics

Total Visits

Views
Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study 73

Total Visits Per Month

July 2024 August 2024 September 2024 October 2024 November 2024 December 2024 January 2025
Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study 8 0 0 2 0 0 0

File Visits

Views
SCOPUS2079701X-2021-20-SID85123097278-a1.pdf 5

Top country views

Views
Russia 35

Top cities views

Views
Kazan 35

Search DSpace


Advanced Search

Browse

My Account

Statistics